Serina Therapeutics, Inc.SERNYSE
Loading
EBITDA as a percentage of revenue
Percentile
P22
Within normal range
vs 2Y Ago
-85x
Contraction
Streak
1 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | -15942.24% | +14.9% |
| 2024 | -18726.79% | -10079.0% |
| 2023 | 187.66% | +136.0% |
| 2022 | -520.99% | -1189.2% |
| 2021 | -40.41% | +99.8% |
| 2020 | -16185.19% | -2378.3% |
| 2019 | -653.07% | -26.7% |
| 2018 | -515.47% | +6.4% |
| 2017 | -550.93% | +22.8% |
| 2016 | -713.93% | - |